BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

neoX Biotech

neoX Biotech logo

Founded
2018
Publications
1

Technologies

AI Companies (Drug Discovery)

neoX Biotech is a biotech company that combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs and multi-specific drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines. Founded in 2018 by two doctors graduated from MIT and Caltech, neoX has been funded by top venture capitals including Sequoia Capital, Morningside Venture Capital, Vision Plus Capital and ZhenFund.

Become a Member to view additional information about this company